EDITORIAL
IL-10 and IPF
IL-10: another therapeutic target in idiopathic pulmonary fibrosis?
Correspondence to:
Correspondence to:
Dr A B Millar
Lung Research Group, Department of Clinical Science at North Bristol, University of Bristol Paul O’Gorman Lifeline Centre, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, UK; Ann.Millar@bristol.ac.uk
The need for appropriately designed clinical trials in IPF
Keywords: interleukin 10; gene therapy; transforming growth factor ß; idiopathic pulmonary fibrosis
| The first 150 words of the full text of this article appear below. |
These are exciting and hopeful times for those involved in the treatment of idiopathic pulmonary fibrosis (IPF). Despite the ever expanding wealth of cellular and molecular biology, translation into clinical trials for IPF has been limited.1 However, in the last 2 years results on three potential therapeutic agents have been published, albeit with limited benefit, with others imminent.2–4 The study by Nakagome et al5 in this issue of Thorax gives further support to the concept of interleukin (IL)-10 as an additional biological therapeutic agent.
In the last 20 years the ability of the scientific community to analyse the biological interactions between cells has led to an information explosion. This has been exemplified by the analysis of cytokine (and growth factor) networks.6 Typically, the initial identification of a protein is followed by its receptor(s), its inhibition or induction by lipopolysaccaride and dexamethasone, and then a cascade of publications
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
